CD4 and neoplasm: This suggests that Tregs in the drLNs can inhibit the development of effector cells such as cytotoxic CD4+ and CD8+ T cells, whereas Tregs in the tumor itself may have dual functions of controlling tumor-promoting inflammation on one hand but suppressing local effector T-cell responses on the other [37].